The Octa Research Team has distanced itself from the comments made by one of its members who said that the AZD1222 Covid-19 vaccine made by British-Swedish drugmaker AstraZeneca would “go to waste” because of its decreased efficacy on the South African variant of the virus.

AstraZeneca vaccine is ready to be used at a homeless shelter in Romford, east London, Wednesday, Feb. 3, 2021. The British health service has started to vaccinate "vulnerable" homeless people. In a study by Oxford University, the AstraZeneca vaccine has been shown to reduce transmission of the virus. (AP Photo/Frank Augstein)

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details